BPI 2026 SERIES · ARTICLE 3 OF 6
COMING SOONNext article coming September 29, 2026
Part of BioMedAna’s six-part series on connected bioprocess intelligence.
BPI 2026 SERIES SIX ARTICLES
Bioprocess intelligence—from cell line development to manufacturing.
A six-part series on connecting process evidence, AI, hybrid digital twins and scientific expertise across the development lifecycle.
Publishing throughout BPI week
New articles appear automatically on their scheduled publication day. Every article remains connected through series navigation and relevant BioMedAna product resources.
BPI 2026 SERIES · ARTICLE 1 OF 6 · 9 MIN READ
AI in Cell Line Development: From More Experiments to Better Decisions
The next opportunity in cell line development isn't simply generating more data. It's connecting experimental evidence, scientific context and AI to make better decisions—and carrying that knowledge forward.
Read article 1 ↗
BPI 2026 SERIES · ARTICLE 2 OF 6 · 11 MIN READ
From Bench to Manufacturing: Using AI to De-Risk Bioprocess Scale-Up
Scale-up is not simply making the same process bigger. As bioreactor scale changes, the physical environment changes—and biology responds. Combining process data, engineering principles, biological context, AI/ML and scientific expertise can help teams understand those changes before they become manufacturing surprises.
Read article 2 ↗BPI 2026 SERIES · ARTICLE 4 OF 6
COMING SOONNext article coming September 30, 2026
Part of BioMedAna’s six-part series on connected bioprocess intelligence.
BPI 2026 SERIES · ARTICLE 5 OF 6
COMING SOONNext article coming October 1, 2026
Part of BioMedAna’s six-part series on connected bioprocess intelligence.
BPI 2026 SERIES · ARTICLE 6 OF 6
COMING SOONNext article coming October 2, 2026
Part of BioMedAna’s six-part series on connected bioprocess intelligence.